Vantin and Clobetasol propionate drug interactions - a phase IV clinical study of FDA data
Summary:
Drug interactions are reported among 3 people who take Vantin and Clobetasol propionate. Common interactions include diarrhoea among females.
The phase IV clinical study analyzes what interactions people who take Vantin and Clobetasol propionate have. It is created by eHealthMe based on reports from the FDA, and is updated regularly. You may use the study as a second opinion to make health care decisions.
Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 700+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.
3 people who take Vantin and Clobetasol propionate together, and have interactions are studied.
What is Vantin?
Vantin has active ingredients of cefpodoxime proxetil. It is used in sinusitis. Currently, eHealthMe is studying from 782 Vantin users.
What is Clobetasol propionate?
Clobetasol propionate has active ingredients of clobetasol propionate. It is used in psoriasis. Currently, eHealthMe is studying from 9,548 Clobetasol propionate users.
Number of Vantin and Clobetasol propionate reports submitted per year:

Common Vantin and Clobetasol Propionate drug interactions by gender *:
female:
- Diarrhoea
- Cellulitis
- Atelectasis
- Blood alkaline phosphatase increased
- Blood bilirubin increased
- Coagulopathy
- Confusional state
- Enterobacter test positive
- Enterococcus test positive
- Gallbladder polyp
male:
n/a
Common Vantin and Clobetasol Propionate drug interactions by age *:
0-1:
n/a
2-9:
n/a
10-19:
n/a
20-29:
n/a
30-39:
n/a
40-49:
n/a
50-59:
n/a
60+:
- Diarrhoea
- Cellulitis
- Atelectasis
- Blood alkaline phosphatase increased
- Blood bilirubin increased
- Coagulopathy
- Confusional state
- Enterobacter test positive
- Enterococcus test positive
- Gallbladder polyp
* Approximation only. Some reports may have incomplete information.
Do you take Vantin and Clobetasol propionate?
Personalize this study to your gender and ageHow to use the study?
You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.
Related studies
Drug side effects by duration, gender and age:
- Vantin side effects (782 reports)
- Clobetasol propionate side effects (9,548 reports)
Browse interactions between Vantin and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zCommon Clobetasol propionate drug interactions:
- Clobetasol propionate and Aspirin: 997 reports
- Clobetasol propionate and Prednisone: 775 reports
- Clobetasol propionate and Omeprazole: 755 reports
- Clobetasol propionate and Methotrexate: 651 reports
- Clobetasol propionate and Humira: 639 reports
- Clobetasol propionate and Vitamin d: 569 reports
- Clobetasol propionate and Lisinopril: 536 reports
- Clobetasol propionate and Gabapentin: 535 reports
- Clobetasol propionate and Furosemide: 513 reports
- Clobetasol propionate and Metformin: 512 reports
Browse interactions between Clobetasol propionate and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zHow the study uses the data?
The study uses data from the FDA. It is based on cefpodoxime proxetil and clobetasol propionate (the active ingredients of Vantin and Clobetasol propionate, respectively), and Vantin and Clobetasol propionate (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study. Patients in the study may take other drugs besides Vantin and Clobetasol propionate.
Who is eHealthMe?
With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 700+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Peg-Intron and Hearing Loss - a second ago
- Vitamin B and Ocular Ischaemic Syndrome - 3 seconds ago
- Oravig and Mupirocin drug interaction - 5 seconds ago
- Risperdal and Epstein-Barr Virus Infection - 6 seconds ago
- Covera-Hs and Sinusitis - Acute - 10 seconds ago
- Antivert and Neutropenic Sepsis - 10 seconds ago
- Covera-Hs and Sinusitis - 10 seconds ago
- Naproxen and Thermal Burn - 14 seconds ago
- Lupron and Therapeutic Response Unexpected - 14 seconds ago
- Clobetasol Propionate and Major Depression - 16 seconds ago